AK-7, as another SIRT2 selective inhibitor, was observed to ameliorate α-synuclein toxicity in vitro and significantly improve behavior abnormality and neurochemical deficits in an MPTP-induced mice model of PD [123,124,125,126,127]. Here, SIRT2 is linked to Parkinson disease.